hematopoietic Archives | BioInformant

In this interview with Dr. Ornella Parolini, Director of the E. Menni Research Center in Italy, we discussed her pioneering research on human placental stem cells. Her research is focused on the immunomodulatory and anti-inflammatory properties of amniotic and chorionic membrane cells. She is also President of the International Placenta Stem Cell Society (IPLASS), making her a globally recognized expert.

In addition to Dr. Robert Harari who holds a wide range of placental stem cell patents, Dr. Parolini is one of the world’s leading experts on placental stem cells and their therapeutic applications.

In this article:

What are Placental Stem Cells?
Interview with Placental Stem Cell Expert, Dr. Parolini
Placental Stem Cell Advantages
International Placental Stem Cell Society
Clinical Applications of Placental Stem Cells

[Read more…]

Headquartered in Jerusalem, Israel, Gamida Cell is best known for its innovative approaches to hematopoietic stem cell therapeutics. Although a small company at the time, Gamida Cell broke onto the global scene in 2003 when it announced a Phase I trial of its StemEx™ product for the treatment of leukemia and lymphoma patients.

StemEx™ was Gamida Cell’s first generation product for theex vivo (“outside the body”) expansion of cord blood stem cells, which can be utilized in hematopoietic stem cell transplantation (HSCT) to treat high risk cancers. Although StemEx™ did not make it beyond Phase II/III trials, this expertise in ex vivo expansion of cord blood lead to the development of Gamida Cell’s current flagship product, NiCord^®, and established Gamida Cell as a global technology leader for functional expansion of cells. [Read more…]

Placental Stem Cells – Interview with Dr. Ornella Parolini of IPLASS

NiCord® to Introduce Paradigm Shift to HSCT? Potential to Provide Transplantation Option To Nearly All In Need

BioInformant's World-Class Clients